{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:37:49Z","timestamp":1783723069979,"version":"3.55.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075144","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T03:59:33Z","timestamp":1381463973000},"page":"e75144","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3\/4A proteases from Multiple Hepatitis C Virus Genotypes"],"prefix":"10.1371","volume":"8","author":[{"given":"Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavankumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk E.","family":"Hevener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Gatuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitanjali","family":"Subramanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Uprichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"ref1","first-page":"S35","article-title":"Natural history of chronic hepatitis C. Hepatology","volume":"36","author":"LB Seeff","year":"2002"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.3748\/wjg.v13.i36.4808","article-title":"Sequence diversity of hepatitis C virus: implications for immune control and therapy","volume":"13","author":"J Timm","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"QL Choo","year":"1989","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81350-1","article-title":"The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site","volume":"87","author":"RA Love","year":"1996","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0092-8674(00)81351-3","article-title":"Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide","volume":"87","author":"JL Kim","year":"1996","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/jmbi.1999.2746","article-title":"Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies","volume":"289","author":"DO Cicero","year":"1999","journal-title":"J Mol Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JVI.74.4.2046-2051.2000","article-title":"Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3\u2032 nontranslated region are essential for virus replication in vivo","volume":"74","author":"AA Kolykhalov","year":"2000","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0960-894X(98)00299-6","article-title":"Peptide-based inhibitors of the hepatitis C virus serine protease","volume":"8","author":"M Llinas-Brunet","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1016\/j.bmcl.2004.05.093","article-title":"SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3\/NS4A serine protease","volume":"14","author":"S Malancona","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrd2661","article-title":"Hepatitis C therapies","volume":"7","author":"I Melnikova","year":"2008","journal-title":"Nature Reviews Drug Discovery"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1053\/j.gastro.2007.01.041","article-title":"SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders","volume":"132","author":"C Sarrazin","year":"2007","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nchembio.1081","article-title":"Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function","volume":"8","author":"SM Saalau-Bethell","year":"2012","journal-title":"Nat Chem Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.coviro.2011.10.019","article-title":"Anti-HCV drugs in the pipeline","volume":"1","author":"PL Yang","year":"2011","journal-title":"Curr Opin Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"20986","DOI":"10.1073\/pnas.1006370107","article-title":"Drug resistance against HCV NS3\/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding","volume":"107","author":"KP Romano","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-7-69","article-title":"Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study","volume":"7","author":"SH Zarkesh-Esfahani","year":"2010","journal-title":"Virol J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.1840190538","article-title":"A proposed system for the nomenclature of hepatitis C viral genotypes","volume":"19","author":"P Simmonds","year":"1994","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.13.2.223-235.2000","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"13","author":"NN Zein","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"JG McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"MG Ghany","year":"2011","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/jhep.2001.20675","article-title":"Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials","volume":"33","author":"JS Cheng","year":"2001","journal-title":"Hepatology"},{"key":"ref22","first-page":"2245","article-title":"Identification of Non-Macrocyclic Small Molecule Inhibitors against the NS3\/4A Serine Protease of Hepatitis C Virus through In-silico Screening. J Chem Inf Model","volume":"52","author":"R Chaudhuri","year":"2012"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1359644602025722","article-title":"Nonleadlikeness and leadlikeness in biochemical screening","volume":"8","author":"GM Rishton","year":"2003","journal-title":"Drug Discov Today"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ab.2012.01.006","article-title":"Reducing agents affect inhibitory activities of compounds: Results from multiple drug targets","volume":"423","author":"H Lee","year":"2012","journal-title":"Anal Biochem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00498250500485115","article-title":"Role of P-glycoprotein in the hepatic metabolism of tacrolimus","volume":"36","author":"H Jeong","year":"2006","journal-title":"Xenobiotica"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"J Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"KJ Blight","year":"2000","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1743-422X-3-89","article-title":"Replication of a hepatitis C virus replicon clone in mouse cells","volume":"3","author":"SL Uprichard","year":"2006","journal-title":"Virol J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"ML Verdonk","year":"2003","journal-title":"Proteins"},{"key":"ref30","unstructured":"Schrodinger (2011) LigPrep, version 2.5. 2.5 ed. New York, NY: Schrodinger, LLC."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a ) prediction and protonation state generation for drug-like molecules","volume":"21","author":"JC Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel inference: understanding AIC and BIC in Model Selection","volume":"33","author":"KP Burnham","year":"2004","journal-title":"Sociological Methods and Research"},{"key":"ref33","unstructured":"Tan SL, ed (2006) Hepatitis C Viruses: Genomes and Molecular Biology: Horizon Bioscience."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2009.04.003","article-title":"Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus","volume":"83","author":"MS Paulson","year":"2009","journal-title":"Antiviral Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"D Lamarre","year":"2003","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"21052","DOI":"10.1073\/pnas.1110534108","article-title":"A macrocyclic HCV NS3\/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target","volume":"108","author":"N Schiering","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:27:58Z","timestamp":1588976878000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075144"}},"subtitle":[],"editor":[{"given":"Birke","family":"Bartosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075144","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]}}}